(Q39468197)

English

Effects of valganciclovir as an add-on therapy in patients with cytomegalovirus-positive glioblastoma: a randomized, double-blind, hypothesis-generating study

scientific article published on 13 March 2013

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Effects of valganciclovir as an add-on therapy in patients with cytomegalovirus-positive glioblastoma: a randomized, double-blind, hypothesis-generating study (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Cytomegalovirus

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

hypothesis generation

1 reference

based on heuristic

inferred from title

Cecilia Söderberg-Nauclér

11

object named as

Cecilia Söderberg-Nauclér

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Giuseppe Stragliotto

1

object named as

Giuseppe Stragliotto

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

10

object named as

Inti Peredo

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

2

object named as

Afsar Rahbar

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

5

object named as

Chato Taher

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

author name string

Nina Wolmer Solberg

3

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Anders Lilja

4

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Abiel Orrego

6

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Birgitta Bjurman

7

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Charlotte Tammik

8

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Petra Skarman

9

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

language of work or name

0 references

publication date

13 March 2013

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

International Journal of Cancer

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

133

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

1204-1213

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28111

21 January 2018

MGMT gene silencing and benefit from temozolomide in glioblastoma

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28111

21 January 2018

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28111

21 January 2018

Consensus on the role of human cytomegalovirus in glioblastoma

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28111

21 January 2018

High prevalence of human cytomegalovirus in prostatic intraepithelial neoplasia and prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28111

21 January 2018

Detection of human cytomegalovirus in normal and neoplastic breast epithelium

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28111

21 January 2018

Detection of human cytomegalovirus in medulloblastomas reveals a potential therapeutic target

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28111

21 January 2018

Significant association of multiple human cytomegalovirus genomic Loci with glioblastoma multiforme samples

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28111

21 January 2018

Sensitive detection of human cytomegalovirus in tumors and peripheral blood of patients diagnosed with glioblastoma

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28111

21 January 2018

Human cytomegalovirus and mucoepidermoid carcinoma of salivary glands: cell-specific localization of active viral and oncogenic signaling proteins is confirmatory of a causal relationship

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28111

21 January 2018

Low levels of Human Cytomegalovirus Infection in Glioblastoma multiforme associates with patient survival; -a case-control study

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28111

21 January 2018

Genetic analysis of cytomegalovirus in malignant gliomas

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28111

21 January 2018

Human cytomegalovirus infection levels in glioblastoma multiforme are of prognostic value for survival

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28111

21 January 2018

Comparison of the ABC/2 estimation technique to computer-assisted volumetric analysis of intraparenchymal and subdural hematomas complicating the GUSTO-1 trial

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28111

21 January 2018

Optimal role of temozolomide in the treatment of malignant gliomas.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28111

21 January 2018

Ex vivo functional analysis, expansion and adoptive transfer of cytomegalovirus-specific T-cells in patients with glioblastoma multiforme.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28111

21 January 2018

Generation of polyclonal CMV-specific T cells for the adoptive immunotherapy of glioblastoma

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28111

21 January 2018

Overall survival of newly diagnosed glioblastoma patients receiving carmustine wafers followed by radiation and concurrent temozolomide plus rotational multiagent chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28111

21 January 2018

Phase II study of bevacizumab plus temozolomide during and after radiation therapy for patients with newly diagnosed glioblastoma multiforme

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28111

21 January 2018

Human cytomegalovirus UL97 open reading frame encodes a protein that phosphorylates the antiviral nucleoside analogue ganciclovir

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28111

21 January 2018

Cytomegalovirus UL97 phosphotransferase mutations that affect susceptibility to ganciclovir

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28111

21 January 2018

The addition of bevacizumab to standard radiation therapy and temozolomide followed by bevacizumab, temozolomide, and irinotecan for newly diagnosed glioblastoma

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28111

21 January 2018

Human cytomegalovirus-encoded chemokine receptor US28 promotes tumorigenesis.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28111

21 January 2018

The human cytomegalovirus-encoded chemokine receptor US28 promotes angiogenesis and tumor formation via cyclooxygenase-2.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28111

21 January 2018

The human cytomegalovirus chemokine receptor US28 mediates vascular smooth muscle cell migration

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28111

21 January 2018

Human cytomegalovirus US28 found in glioblastoma promotes an invasive and angiogenic phenotype

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28111

21 January 2018

HCMV-encoded chemokine receptor US28 mediates proliferative signaling through the IL-6-STAT3 axis

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28111

21 January 2018

The cytomegalovirus-encoded chemokine receptor US28 promotes intestinal neoplasia in transgenic mice

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28111

21 January 2018

Is HCMV a tumor promoter?

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28111

21 January 2018

The story of human cytomegalovirus and cancer: increasing evidence and open questions

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28111

21 January 2018

Small molecule inhibitors of the host cell COX/AREG/EGFR/ERK pathway attenuate cytomegalovirus-induced pathogenesis

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28111

21 January 2018

Cytomegalovirus infection leads to pleomorphic rhabdomyosarcomas in Trp53+/- mice

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28111

21 January 2018

Identifiers

10.1002/IJC.28111

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39468197&oldid=1829683679"